Effects of chemotherapeutic agents for testicular cancer on the male rat reproductive system, spermatozoa, and fertility

Journal of Andrology

Volumn 27, Issue 2, 2006, Pages 189-200

  Bieber, Adrienne M ^a   Marcon, Ludovic ^a   Hales, Barbara F ^a   Robaire, Bernard ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b Department of Pharmacology and Therapeutics ^*  (Canada)

Author keywords

Bleomycin; cis Platinum; Epididymis; Etoposide; Flagellar defect; Progeny outcome; Testis

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; EMBRYOPATHY; EPIDIDYMIS; FETUS DEVELOPMENT; FLAGELLUM; GENITAL SYSTEM; LITTER SIZE; MALE; MALE FERTILITY; MORTALITY; NONHUMAN; POSTNATAL DEVELOPMENT; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROGENY; RAT; SEX RATIO; SPERMATOGENESIS; SPERMATOZOON; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; TESTIS CANCER; TESTIS WEIGHT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; DISEASE MODELS, ANIMAL; EPIDIDYMIS; ETOPOSIDE; FEMALE; FERTILITY; MALE; ORGAN SIZE; PREGNANCY; PREGNANCY OUTCOME; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCTION; SPERMATOZOA; TESTICULAR NEOPLASMS;

EID: 33644528452     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: 10.2164/jandrol.05103     Document Type: Article

References (46)

1. Adami HO, Bergstrom R, Mohner M, Zatonski W, Storm H, Ekbom A, Tretli S, Teppo L, Ziegler H, Rahu M. Testicular cancer in nine northern European countries. Int J Cancer. 1994;59:33-38.
2. Bachmann K, Pardoe D, White D. Scaling basic toxicokinetic parameters from rat to man. Environ Health Perspect. 1996;104:400-407.
3. Benedetto P. Chemotherapy of testis cancer. Cancer Control. 1999;6:549-559.
4. Byrne J, Mulvihill JJ, Connelly RR, Austin DA, Holmes GE, Holmes FF, Latourette HB, Meigs JW, Strong LC, Myers MH. Reproductive problems and birth defects in survivors of Wilms' tumor and their relatives. Med Pediatr Oncol. 1988;16:233-240.
5. Chatterjee A, Singh R, Chatterjee R. Dexamethasone modulation of gestation length and parturition in rats. Pharmacol Res. 1993;27:359-364.
6. Deane L, Sharir S, Jarvi K, Zini A. High levels of sperm DNA denaturation as the sole semen abnormality in a patient after chemotherapy for testis cancer. J Androl. 2004;25:23-24.
7. De Mas P, Daudin M, Vincent MC, Bourrouillou G, Calvas P, Mieusset R, Bujan L. Increased aneuploidy in spermatozoa from testicular tumour patients after chemotherapy with cisplatin, etoposide and bleomycin. Hum Reprod. 2001;16:1204-1208.
8. Forman D, Moller H. Testicular cancer. Cancer Surv. 1994;19-20:323-341.
9. Hansen PV, Glavind K, Panduro J, Pedersen M. Paternity in patients with testicular germ cell cancer: pretreatment and post-treatment findings. Eur J Cancer. 1991;27:1385-1389.
10. Horowitz E, Zhang Z, Jones BH, Moss SB, Ho C, Wood JR, Wang X, Samuel MD, Strauss JF III. Patterns of expression of sperm flagellar genes: early expression of genes encoding axonemal proteins during the spermatogenic cycle and shared features of promoters of genes encoding central apparatus proteins. Mol Hum Reprod. 2005;11:307-317.
11. Howell SJ, Shalet SM. Testicular function following chemotherapy. Hum Reprod Update. 2001;7:363-369.
12. Huttner KM, Pudney J, Milstone DS, Ladd D, Seidman JG. Flagellar and acrosomal abnormalities associated with testicular HSV-tk expression in the mouse. Biol Reprod. 1993;49:251-261.
13. Huyghe E, Matsuda T, Daudin M, Chevreau C, Bachaud JM, Plante P, Bujan L, Thonneau P. Fertility after testicular cancer treatments: results of a large multicenter study. Cancer. 2004;100:732-737.
14. Huynh PN, Hikim AP, Wang C, Stefonovic K, Lue YH, Leung A, Atienza V, Baravarian S, Reutrakul V, Swerdloff RS. Long-term effects of triptolide on spermatogenesis, epididymal sperm function, and fertility in male rats. J Androl. 2000;21:689-699.
15. Jedrzejczak P, Taszarek-Hauke G, Korman M, Kopaczynski P, Pawelczyk L. The sperm quality in young patients before cancer therapy. Przegl Lek. 2004;61:141-145.
16. Klinefelter GR, Gray LE, Suarez JD. The method of sperm collection significantly influences sperm motion parameters following ethane dimethanesulfonate administration in the rat. Reprod Toxicol. 1991;5:39-44.
17. Lahdetie J, Keiski A, Suutari A, Toppari J. Etoposide (VP-16) is a potent inducer of micronuclei in male rat meiosis: spermatid micronucleus test and DNA flow cytometry after etoposide treatment. Environ Mol Mutagen. 1994;24:192-202.
18. Lampe H, Horwich A, Norman A, Nicholls J, Dearnaley DP. Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol. 1997;15:239-245.
19. Lee CK, Lee CU, Kim JH, Son BC, Kim DH, Lee CH, Kim HD, Kim JW, Yoon YD, Kang SG, Moon DH. Effects of Aroclor 1254 on the expression of rat placental PRL-family genes. Mol Cells. 2003;15:114-121.
20. Leonhardt DE, Coleman LW, Bradshaw WS. Perinatal toxicity of ethylene glycol dimethyl ether in the rat. Reprod Toxicol. 1991;5:157-162.
21. Martin RH, Ernst S, Rademaker A, Barclay L, Ko E, Summers N. Chromosomal abnormalities in sperm from testicular cancer patients before and after chemotherapy. Hum Genet. 1997;99:214-218.
22. Marty MS, Loch-Caruso R. 2-Methoxyethanol inhibits gap junctional communication in rat myometrial myocytes. Cell Biol Toxicol. 1998;14:199-210.
23. Masuda H, Fujihira S, Ueno H, Kagawa M, Katsuoka Y, Mori H. Ultrastructural study on cytotoxic effects of cyclosporine A in spermiogenesis in rats. Med Electron Microsc. 2003;36:183-191.
24. Mead GM, Stenning SP. The International Germ Cell Consensus Classification: a new prognostic factor-based staging classification for metastatic germ cell tumours. Clin Oncol (R Coll Radiol). 1997;9:207-209.
25. Olson GE, Winfrey VP, Hill KE, Burk RF. Sequential development of flagellar defects in spermatids and epididymal spermatozoa of selenium-deficient rats. Reproduction. 2004;127:335-342.
26. Olson GE, Winfrey VP, Nagdas SK, Hill KE, Burk RF. Selenoprotein P is required for mouse sperm development. Biol Reprod. 2005;73:201-211.
27. Petersen PM, Skakkebaek NE, Rorth M, Giwercman A. Semen quality and reproductive hormones before and after orchidectomy in men with testicular cancer. J Urol. 1999a;161:822-826.
28. Petersen PM, Skakkebaek NE, Vistisen K, Rorth M, Giwercman A. Semen quality and reproductive hormones before orchidectomy in men with testicular cancer. J Clin Oncol. 1999b;17:941-947.
29. Rands PL, Newhouse CL, Stewart JL, Bradshaw WS. Indicators of developmental toxicity following prenatal administration of hormonally active compounds in the rat. II. Pattern of maternal weight gain. Teratology. 1982;25:45-51.
30. Robaire B, Smith S, Hales BF. Suppression of spermatogenesis by testosterone in adult male rats: effect on fertility, pregnancy outcome and progeny. Biol Reprod. 1984;31:221-230.
31. Robb GW, Amann RP, Killian GJ. Daily sperm production and epididymal sperm reserves of pubertal and adult rats. J Reprod Fertil. 1978;54:103-107.
32. Russell LB, Hunsicker PR, Kerley M, Pyle A, Saxton AM. Etoposide exposure during male mouse pachytene has complex effects on crossing-over and causes nondisjunction. Mutat Res. 2004;565:61-77.
33. Russell LB, Hunsicker PR, Kerley MK, Johnson DK, Shelby MD. Bleomycin, unlike other male-mouse mutagens, is most effective in spermatogonia, inducing primarily deletions. Mutat Res. 2000;469:95-105.
34. Seed J, Chapin RE, Clegg ED, Dostal LA, Foote RH, Hurtt ME, Klincfelter GR, Makris SL, Perreault SD, Schrader S, Seyler D, Sprando R, Treinen KA, Veeramachaneni DN, Wise LD. Methods for assessing sperm motility, morphology, and counts in the rat, rabbit, and dog: a consensus report. ILSI Risk Science Institute Expert Working Group on Sperm Evaluation. Reprod Toxicol. 1996;10:237-244.
35. Seethalakshmi L, Flores C, Kinkead T, Carboni AA, Malhotra RK, Menon M. Effects of subchronic treatment with cis-platinum on testicular function, fertility, pregnancy outcome, and progeny. J Androl. 1992;13:65-74.
36. Senturia YD, Peckham CS, Peckham MJ. Children fathered by men treated for testicular cancer. Lancet. 1985;2:766-769.
37. Slott VL, Suarez JD, Poss PM, Linder RE, Strader LF, Perreault SD. Optimization of the Hamilton-Thorn Computerized Sperm Motility Analysis System for Use with Rat Spermatozoa in Toxicological Studies. Fundam Appl Toxicol. 1993;21:298-307.
38. Stahl O, Eberhard J, Jepson K, Spano M, Cwikiel M, Cavallin-Stahl E, Giwercman A. The impact of testicular carcinoma and its treatment on sperm DNA integrity. Cancer. 2004;100:1137-1144.
39. Stephenson WT, Poirier SM, Rubin L, Einhorn LH. Evaluation of reproductive capacity in germ cell tumor patients following treatment with cisplatin, etoposide, and bleomycin. J Clin Oncol. 1995;13:2278-2280.
40. Syntin P, Robaire B. Sperm structural and motility changes during aging in the Brown Norway rat. J Androl. 2001;22:235-244.
41. Thomas C, Cans C, Pelletier R, De Robertis C, Hazzouri M, Sele B, Rousseaux S, Hennebicq S. No long-term increase in sperm aneuploidy rates after anticancer therapy: sperm fluorescence in situ hybridization analysis in 26 patients treated for testicular cancer or lymphoma. Clin Cancer Res. 2004;10:6535-6543.
42. Tomomasa H, Oshio S, Ashizawa Y, Kamiyama Y, Okano Y, Iiyama T, Sato S, Shimizu H, Umeda T. Gonadal function in patients with testicular germ cell tumors. Arch Androl. 2002;48:405-415.
43. Toth GP, Stober JA, Zenick H, Read EJ, Christ SA, Smith MK. Correlation of sperm motion parameters with fertility in rats treated subchronically with epichlorohydrin. J Androl. 1991;12:54-61.
44. Trasler JM, Hales BF, Robaire B. Paternal cyclophosphamide treatment of rats causes fetal loss and malformations without affecting male fertility. Nature. 1985;316:144-146.
45. White RD, Allen SD, Bradshaw WS. Delay in the onset of parturition in the rat following prenatal administration of developmental toxicants. Toxicol Lett. 1983;18:185-192.
46. Zimmerman SA, Clevenger WR, Brimhall BB, Bradshaw WS. Diethylstilbestrol-induced perinatal lethality in the rat. II. Perturbation of parturition. Biol Reprod. 1991;44:583-585.